Norge -
norsk -
Statens legemiddelverk
relifex 1 g
meda - asker - nabumeton - oppløselig tablett - 1 g
Norge -
norsk -
Statens legemiddelverk
relifex 1 g
viatris as - nabumeton - tablett, filmdrasjert - 1 g
Norge -
norsk -
Statens legemiddelverk
dacarbazine lipomed 200 mg
lipomed gmbh - dakarbazin - pulver til injeksjons-/infusjonsvæske, oppløsning - 200 mg
Norge -
norsk -
Statens legemiddelverk
ketesse 25 mg
menarini international o.l. s.a. - deksketoprofentrometamol - tablett, filmdrasjert - 25 mg
Norge -
norsk -
Statens legemiddelverk
orodek 25 mg
menarini international o.l. s.a. - deksketoprofentrometamol - tablett, filmdrasjert - 25 mg
Norge -
norsk -
Statens legemiddelverk
trimonil retard 300 mg
desitin arzneimittel gmbh - karbamazepin - depottablett - 300 mg
Norge -
norsk -
Statens legemiddelverk
trimonil retard 150 mg
desitin arzneimittel gmbh - karbamazepin - depottablett - 150 mg
Norge -
norsk -
Statens legemiddelverk
trimonil retard 600 mg
desitin arzneimittel gmbh - karbamazepin - depottablett - 600 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
lumeblue (previously known as methylthioninium chloride cosmo)
alfasigma s.p.a. - metyltioniniumklorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.